Biomimetic Diels-Alder cyclizations for the construction of the brevianamide, paraherquamide, sclerotamide, asperparaline and VM55599 ring systems

Bioorganic and Medicinal Chemistry

Volumn 6, Issue 8, 1998, Pages 1233-1241

  Williams, Robert M ^a   Sanz Cervera, Juan F ^b   Sancenón, Félix ^b   Marco, J Alberto ^b   Halligan, Kathleen M ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ASPERPARALINE; BICYCLO COMPOUND; BREVIANAMIDE; PARAHERQUAMIDE; SCLEROTAMIDE; UNCLASSIFIED DRUG; VM 55599;

ARTICLE; CHEMICAL REACTION; CYCLIZATION; PARTIAL DRUG SYNTHESIS; REACTION ANALYSIS; STEREOCHEMISTRY;

ALKALOIDS; ANTHELMINTICS; CYCLIZATION; INDOLIZINES; PIPERAZINES; SPIRO COMPOUNDS; STEREOISOMERISM;

BETULACEAE;

EID: 0031710510     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(98)00102-3     Document Type: Article

References (39)

1. (a) Yamazaki, M.; Okuyama, E., Tetrahedron Lett. 1981, 22, 135.
2. (b) Ondeyka, J. G.; Goegelman, R. T.; Schaeffer, J. M.; Kelemen, L; Zitano, L. J. Antibiotics 1990, 43, 1375.
3. (c) Liesch, J. M.; Wichmann, C. F. J. Antibiotics 1990, 43, 1380.
4. (d) Blanchflower, S. E.; Banks, R. M.; Everett, J. R.; Manger, B. R.; Reading, C. J. Antibiotics 1991, 44, 492.
5. (a) Polonsky, J.; Merrien, M-A.; Prange, T.; Pascard, C. J. Chem. Soc. Chem. Comm. 1980, 601.
6. (b) Prange, T.; Billion, M-A.; Vuilhorgne, M.; Pascard, C.; Polonsky, J. Tetrahedron Lett. 1981, 22, 1977.
7. Whyte, A. C.; Gloer, J. B. J. Nat. Prod. 1996, 59, 1093.
8. (a) Birch, A. J.; Wright, J. J. J. Chem. Soc. Chem. Comm. 1969, 644.
9. (b) Birch, A. J.; Wright, J. J. Tetrahedron 1970, 26, 2329.
10. (c) Birch, A. J.; Russell, R. A. Tetrahedron 1972, 28, 2999.
11. (d) Bird, B. A.; Remaley, A. T.; Campbell, I. M. Appl. Environ. Microbiol. 1981, 42, 521.
12. (e) Bird, B. A.; Campbell, I. M. Appl. Environ. Microbiol. 1982, 43, 345.
13. (f) Robbers, J. E.; Straus, J. W. Lloydia 1975, 38, 355.
14. (g) Paterson, R. R. M.; Hawksworth, D. L. Trans. Br. Mycol. Soc. 1985, 85, 95.
15. (h) Wilson, B. J.; Yang, D. T. C.; Harris, T. M. Appl. Microbiol. 1973, 26, 633.
16. (i) Coetzer, J. Acta Cryst. 1974, B30, 2254.
17. Blanchflower, S. E.; Banks, R. M.; Everett, J. R.; Reading, C. J. Antibiotics 1993, 46, 1355.
18. (a) Hayashi, H.; Nishimoto, Y.; Nozaki, H. Tetrahedron Lett. 1997, 38, 5655.
19. (b) Banks, R. M.; Blanchflower, S. E.; Everett, J. R.; Manger, B. R.; Reading, C. J. Antibiotics 1997, 50, 840.
20. (a) Baldas, J.; Birch, A. J.; Russell, R. A. J. Chem. Soc. Perkin Trans I 1974, 50.
21. (b) Birch, A. J. Agr. Food Chem. 1971, 19, 1088.
22. (c) Sanz-Cervera, J. F.; Glinka, T.; Williams, R. M. J. Am. Chem. Soc. 1993, 115, 347.
23. (d) Sanz-Cervera, J. F.; Glinka, T.; Williams, R. M. Tetrahedron 1993, 49, 8471.
24. (e) Kuo, M. S.; Wiley, V. H.; Cialdella, J. I.; Yurek, D. A.; Whaley, H. A.; Marshall, V. P. J. Antibiotics 1996, 49, 1006.
25. (a) Shoop, W. L.; Egerton, J. R.; Eary, C. H.; Suhayda, D. J. Parasitol. 1990, 76, 349.
26. (b) Shoop, W. L.; Michael, B. F.; Haines, H. W.; Eary, C. H. Vet. Parasitol. 1992, 43, 259.
27. (c) Shoop, W. L.; Haines, H. W.; Eary,C. H.; Michael, B. F. Am. J. Vet. Res. 1992, 53, 2032.
28. (d) Ostlind, D. A.; Mickle, W. G.; Ewanciw, D. V.; Andriuli, F. J.; Campbell, W. C.; Hernandez, S.; Mochales, S.; Munguira, E. Res. Vet. Sci. 1990, 48, 260.
29. (e) Schaeffer, J. M.; Blizzard, T. A.; Ondeyka, J.; Goegelman, R.; Sinclair, P. J.; Mrozik, H. Biochem. Pharmacol. 1992, 43, 679.
30. Porter, A. E. A.; Sammes, P. G. J. Chem. Soc. Chem. Comm. 1970, 1103.
31. The syn-/anti-relationship refers to the relative stereochemistry between the C-19 stereogenic center (brevianamide numbering) and the cyclic amino acid residue (proline, β-methylproline, or pipecolic acid):
32. Williams, R. M.; Kwast, E.; Coffman, H.; Glinka, T. J. Am. Chem. Soc. 1989, 111, 3064.
33. Domingo, L. R.; Sanz-Cervera, J. F.; Williams, R. M.; Picher, M. T.; Marco, J. A. J. Org. Chem. 1997, 62, 1662.
34. Kametani, T.; Kanaya, N.; Ihara, M. J. Chem. Soc. Perkin Trans. I 1981, 959. It should be noted that deoxybrevianamide E, the minor isomer from this procedure could be used with equal efficacy in this synthesis.
35. Williams, R. M.; Kwast, E. Tetrahedron Lett. 1989, 30, 451.
36. Stocking, E. M.; Sanz-Cervera, J. F.; Williams, R. M.; Unkefer, C. J. J. Am. Chem. Soc. 1996, 118, 7008.
37. For relevant work, see: (a) Dunkerton, L. V.; Chen, H.; McKillican, B. P. Tetrahedron Lett. 1988, 29, 2539.
38. (b) Fabre, J. L.; Farge, D.; James, C.; Lave, D. Tetrahedron Lett. 1985, 26, 5447.
39. This work has been communicated in preliminary form: Williams, R. M.; Sanz-Cervera, J. F.; Sancenon, F.; Marco, J. A.; Halligan, K. J. Am. Chem. Soc. 1998, 120, 1090.